Mechanisms for fibrate lipid-lowering drugs in enhancing bladder cancer immunotherapy by inhibiting CD276 expression. Li C, Liu J, Wang L, Xiong W, et al. BMC Cancer 2025;25:1404.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li C, Liu J, Wang L, Xiong W, et al. Mechanisms for fibrate lipid-lowering drugs in enhancing bladder cancer immunotherapy by inhibiting CD276 expression. BMC Cancer 2025;25:1404.
PMID: 40887616